City

Ann Arbor (1)

Bron (1)

Columbus (1)

Condition

Lung Disease With Systemic Sclerosis (2)

Isolated Angiitis of Central Nervous System (1)

Lung Disease Interstitial Diffuse (1)

Lung Diseases, Interstitial (1)

Lupus Erythematosus, Systemic (1)

Systemic Vasculitis (1)

Overall Status

Terminated (1)

Unknown status (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Hospices Civils de Lyon (1)

Joseph Mccune (1)

Collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

National Institutes of Health (NIH) (1)

Intervention

depot leuprolide acetate 3.75 mg (1)

epidemiology, healthcare costs in non-ipf pf-ild and ssc-ild (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

lung disease with systemic sclerosis

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Prognosis and Patient Healthcare Costs in France, 2010-2017

Unknown status

Lung Diseases, Interstitial
Lung Disease With Systemic Sclerosis

epidemiology, healthcare costs in non-IPF PF-ILD and SSc-ILD

Bron, France

Hôpital Cardiologique Louis Pradel

Mar 6, 2019

Lupus Erythematosus, Systemic, Systemic Vasculitis, Isolated Angiitis of CNS Trial in Ann Arbor, Columbus (depot leuprolide

Terminated

Has Results

Lupus Erythematosus, Systemic
+4 more

depot leuprolide acetate 3.75 mg
Placebo

Ann Arbor, Michigan
+1 more

May 23, 2017